Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ake Danielsson

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Lakartidningen|January 15, 2004
[A new life with MARS? The benefit of a new method still written in the stars]Ake Danielsson
Lakartidningen|October 16, 2004
[When should liver biopsy be considered? Slightly increased ALAT can indicate steatosis--but a histological test is necessary for prognosis]Ake Danielsson
Lakartidningen|March 16, 2006
[Discovery of Helicobacter pylori resulted in a paradigm shift. This will probably soon be medical history]Ake Danielsson
Lakartidningen|July 22, 2010
[Autoimmune hepatitis often requires lifelong treatment]Mårten Werner, Ake Danielsson
Lakartidningen|June 28, 2006
[Lhx2 seems to inhibit the development of liver cirrhosis. Gene discovery makes the development of drugs against this enormous health problem possible]Leif Carlsson, Ake Danielsson
Lakartidningen|January 14, 2003
[Video capsule--a promising "bean"]Ake Danielsson, Ole Suhr
Lakartidningen|July 22, 2010
[Liver diseases in focus for Swedish research]Stefan Lindgren, Ake Danielsson
Peptides|February 5, 2002
Peptide YY in gastrointestinal disordersMagdy El-Salhy, Ole Suhr, Ake Danielsson
Scandinavian Journal of Gastroenterology|September 14, 2007
Gastrointestinal symptoms are associated with hypothalamic-pituitary-adrenal axis suppression in healthy individualsPontus Karling, Karl-Fredrik Norrback, Rolf Adolfsson, et al.
Immunology|April 5, 2005
Reduced susceptibility to dextran sulphate sodium-induced colitis in the interleukin-2 heterozygous (IL-2) mouseMalin Sund, Li Li Xu, Arman Rahman, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Lakartidningen|January 15, 2004
[A new life with MARS? The benefit of a new method still written in the stars]Ake Danielsson
Lakartidningen|October 16, 2004
[When should liver biopsy be considered? Slightly increased ALAT can indicate steatosis--but a histological test is necessary for prognosis]Ake Danielsson
Lakartidningen|March 16, 2006
[Discovery of Helicobacter pylori resulted in a paradigm shift. This will probably soon be medical history]Ake Danielsson
Lakartidningen|July 22, 2010
[Autoimmune hepatitis often requires lifelong treatment]Mårten Werner, Ake Danielsson
Lakartidningen|June 28, 2006
[Lhx2 seems to inhibit the development of liver cirrhosis. Gene discovery makes the development of drugs against this enormous health problem possible]Leif Carlsson, Ake Danielsson
Lakartidningen|January 14, 2003
[Video capsule--a promising "bean"]Ake Danielsson, Ole Suhr
Lakartidningen|July 22, 2010
[Liver diseases in focus for Swedish research]Stefan Lindgren, Ake Danielsson
Peptides|February 5, 2002
Peptide YY in gastrointestinal disordersMagdy El-Salhy, Ole Suhr, Ake Danielsson
Scandinavian Journal of Gastroenterology|September 14, 2007
Gastrointestinal symptoms are associated with hypothalamic-pituitary-adrenal axis suppression in healthy individualsPontus Karling, Karl-Fredrik Norrback, Rolf Adolfsson, et al.
Immunology|April 5, 2005
Reduced susceptibility to dextran sulphate sodium-induced colitis in the interleukin-2 heterozygous (IL-2) mouseMalin Sund, Li Li Xu, Arman Rahman, et al.
Pageof 3